Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Clinigen acquires Idis for £225m

Acquisition makes them the global leader in unlicensed medicines

Roche Basel Switzerland

Roche maintains top place in biologic sales

But the looming threat of biosimilars is set to shake up the market

- PMLiVE

Novartis still hungry after absorbing GSK oncology

CEO says firm is looking to strengthen pipelines in its three businesses

- PMLiVE

Recipharm Italy appoints new general manager

Dr Giorgio Bruno has worked with companies such as AstraZeneca and Corden

- PMLiVE

Paul Blackburn launches search firm People Gallery

New company to have a particular focus on health

ABPI London offices

Pharma must engage on the affordability question, says ABPI

UK pharma trade body says the industry must be willing to discuss drug pricing

- PMLiVE

Merck’s breakthrough HCV drug aces trial

Grazoprevir/elbasvir showed efficacy in phase II and III trials

- PMLiVE

EUSA Pharma appoints Lee Morley as its new chief executive

UK specialty pharmaceutical company also adds Göran Ando to its board

- PMLiVE

MRC Technology names finance director

Andrew Mercieca took up the role on April 1

Boehringer Ingelheim headquarters

Boehringer’s sales drop after ‘intense and challenging’ year

US operations hit hard by healthcare reforms and insurance consolidation

- PMLiVE

Saxenda debuts in US with $1,000-a-month price tag

It is the first market for Novo Nordisk’s obesity therapy

Roche Basel Switzerland

Roche adds kidney cancer to anti-PD-L1 programme

Inhibitor already indicated for lung, bladder and breast cancer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links